Inflammation Research

, Volume 45, Issue 10, pp 494–498 | Cite as

Proteoglycan degrading activity in granulomatous inflammation: Comparison between the C57bl/6 and C57bg/bg mouse

  • D. Prigent
  • M. M. Trancart
  • M. P. Seed
  • D. A. Willoughby
Original Research Papers


Objective and Design:

Proteoglycan (GAG) and collagen are lost from cartilage juxtaposed to murine granulomatous tissue in both control and C57bg/bg (elastase deficient mice). The objective was to extract and characterise proteoglycan degrading activity within granulomas of both strains.


15 animals (female C57bl/6 and C57bg/bg mice) per group were used.


Cotton-wrapped rat femoral head cartilages were implanted subcutaneously into the dorsum of the mice and the granulomas excised fourteen days later.


Granuloma and granuloma cell-granule preparations were fractionated within a detergent-based buffer and tested for their abilities to degrade cartilage in vitro in the presence and absence of enzyme inhibitors. Elastase and cathepsin G activities were also assessed using specific substrates. Statistical significance was calculated using Student's t-test.


Extracts from both strains induced the loss of cartilage GAG. This was correlated with cathepsin G activity (r=0.96) and was inhibited by a specific cathepsin-G inhibitor (95%, p<0.001), but not specific elastase or metalloproteinase inhibitors. Elastase activity but not that of cathepsin G was absent in the beige mice, whilst both enzymes were active in the controls.


It appears that neutrophil cathepsin G may play an important role in the degradation of cartilage proteoglycan in the murine cotton-pellet granuloma in both C57bl/6 and C57bg/bg.

Key words

Cartilage degradation model Beige mouse Proteoglycan Cathepsin G Elastase 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Wooley DE, Crossley MJ, Evanson JM. Collagenase at sites of cartilage erosion in the rheumatoid joint. Arthr Rheum 1977;20:1231–9.CrossRefGoogle Scholar
  2. [2]
    McCachren SS. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthr Rheum 1991;34:1085–93.CrossRefGoogle Scholar
  3. [3]
    Larbre JP, Moore AR, Da Silva JAP, Iwamura H, Ionnaou Y, Willoughby DA. Direct degradation of articular cartilage by rheumatoid synovial fluid-contribution of proteolytic enzymes. J Rheumatol 1994;21:1796–801.PubMedGoogle Scholar
  4. [4]
    De Brito FB, Holmes MJ, Carney SL, Willoughby DA. Drug effects on a novel model of connective tissue breakdown. Agents Actions 1987;21:287–9.CrossRefGoogle Scholar
  5. [5]
    Bottomley KMK, Griffith SRJ, Rising TG, Steward A. A modified mouse air pouch model for evaluating the effects of compounds on granuloma induced cartilage degradation. Br J Pharmacol 1988;93:627–35.CrossRefGoogle Scholar
  6. [6]
    Trancart MM, Chalmeigné N, Girardot C, Zarpanelian C, Prigent D. Gelatinase is the main matrix metalloprotease involved in granuloma-induced cartilage degradation. Int J Tiss Reac 1992;14:287–94.Google Scholar
  7. [7]
    Huet G, Flipo RM, Richet C, Theibaut C, Demeyer D, Balduyk M, et al. Measurement of elastase and cysteine proteinases in synovial fluid of patients with rheumatoid arthritis, seronegative spondylo-arthropathies, and osteoarthritis. Clin Chem 1992;38:1694–7.PubMedGoogle Scholar
  8. [8]
    Nakagawa T, Momohara S, Fujita K, Kodama T, Yamada H, Nagai Y: Serine proteinase in articular cartilage, subchondral bone marrow and synovial fluid in human osteoarthritis and rheumatoid arthritis. Biomed Res 1995;16:11–20.CrossRefGoogle Scholar
  9. [9]
    McDonnell J, Lobner JM, Knight WB, Lark MW, Green B, Poe M, et al. Comparison of the proteoglycanolytic activities of human-leukocyte elastase and human cathepsin G in vitro and in vivo. Conn Tiss Res 1993;30:1–9.CrossRefGoogle Scholar
  10. [10]
    Iwamura I, Moore AR, Willoughby DA. Interaction between neutrophil-derived elastase and reactive oxygen species in cartilage degradation. Bioch Biophys Acta 1993;1156:295–301.CrossRefGoogle Scholar
  11. [11]
    Levine JJ, Sherry DD, Strickland DK, Ilowite NT. Intra-articular alpha-2-macroglobulin complexes and proteolytic activity in children with juvenile rheumatoid arthritis. Pediatr Res 1993;34:204–7.CrossRefGoogle Scholar
  12. [12]
    Seed MP, Trancart MM, Alam CAS, Moore AR, Azam Z, Prigent D, et al. Metalloproteinase regulation and cartilage matrix loss during granulamatous inflammation in elastase deficient Chediak-Higashi mice. Inflamm Res 1995;44 Suppl 3:S255.Google Scholar
  13. [13]
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75.PubMedGoogle Scholar
  14. [14]
    Farndale RW, Christine AS, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage. Conn Tiss Res 1982;9:247–8,CrossRefGoogle Scholar
  15. [15]
    Rest RF. Human neutrophil and mast cell proteases implicated in inflammation. Meth Enzymol 1988;163:309–27.CrossRefGoogle Scholar
  16. [16]
    Pettipher R, Edwards J, Cruwys S, Jessup E, Beesley J, et al. Pathogenesis of antigen-induced arthritis in mice deficient in neutrophil elastase and cathepsin G. Am J Pathol 1990; 37:1077–82.Google Scholar
  17. [17]
    Schalwijk J, Joosten LAB, van den Berg WB, van de Putte LBA. Experimental arthritis in C57black/6 and beige (Chediak-Higashi) mice: in vivo and in vitro observations on cartilage degradation. Ann Rheum Dis 1988;47:940–6.CrossRefGoogle Scholar
  18. [18]
    Schalkwijk J, Joosten LAB, van den Berg WB, van de Putte LBA. Antigen induced arthritis in beige (Chediak-Higashi) mice. Ann Rheum Dis 1990;49:607–10.CrossRefGoogle Scholar
  19. [19]
    Takeuchi K, Wood H, Swank RT. Lysosomal elastase and cathepsin G in beige mice. J Exp Med 1986;163:665–77.CrossRefGoogle Scholar
  20. [20]
    Gardi C, Cavarra E, Calzoni P, Marcolongo P, De Santi M, Martorana PA, et al. Neutrophil lysosmal dysfunctions in mutant C57B1/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors. Biochem J 1994;299:237–47.CrossRefGoogle Scholar
  21. [21]
    Karran EH, Young TJ, Markwell RE, Harper GP. In vivo model of cartilage degradation-effects of a matrix metalloproteinase inhibitor. Ann Rheum Dis 1995;54:662–9.CrossRefGoogle Scholar
  22. [22]
    Ogata Y, Enghild JJ, Nagase H. Matrix metalloproreinase-3 (stromelysin) activates the precursor for the human metallo-proteinase-9. J Biol Chem 1992;267:3581–4.PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1996

Authors and Affiliations

  • D. Prigent
    • 1
  • M. M. Trancart
    • 1
  • M. P. Seed
    • 2
  • D. A. Willoughby
    • 2
  1. 1.Laboratoires Jacques LOGEAISTrappesFrance
  2. 2.Experimental PathologySaint Bartholomew's Hospital Medical CollegeLondonUK

Personalised recommendations